These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 7559796
21. Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells. Kawaguchi M, Hosotani R, Kogire M, Ida J, Doi R, Koshiba T, Miyamoto Y, Tsuji S, Nakajima S, Kobayashi H, Masui T, Imamura M. Int J Oncol; 2000 Jan; 16(1):37-41. PubMed ID: 10601546 [Abstract] [Full Text] [Related]
22. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells. Sheikh MS, Shao ZM, Hussain A, Clemmons DR, Chen JC, Roberts CT, LeRoith D, Fontana JA. J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042 [Abstract] [Full Text] [Related]
23. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells. Sun L, Wu S, Coleman K, Fields KC, Humphrey LE, Brattain MG. Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724 [Abstract] [Full Text] [Related]
24. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II. Rutten AA, Bermudez E, Stewart W, Everitt JI, Walker CL. Cancer Res; 1995 Aug 15; 55(16):3634-9. PubMed ID: 7627973 [Abstract] [Full Text] [Related]
25. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model. Coffey RJ, Goustin AS, Soderquist AM, Shipley GD, Wolfshohl J, Carpenter G, Moses HL. Cancer Res; 1987 Sep 01; 47(17):4590-4. PubMed ID: 2887281 [Abstract] [Full Text] [Related]
31. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells. Scott CD, Weiss J. J Cell Physiol; 2000 Jan 01; 182(1):62-8. PubMed ID: 10567917 [Abstract] [Full Text] [Related]
32. Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells. Chang J, Park K, Bang YJ, Kim WS, Kim D, Kim SJ. Cancer Res; 1997 Jul 15; 57(14):2856-9. PubMed ID: 9230189 [Abstract] [Full Text] [Related]
33. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha. Duddy SK, Earp HS, Russell WE, Smith GJ, Grisham JW. Cell Growth Differ; 1995 Mar 15; 6(3):251-61. PubMed ID: 7794793 [Abstract] [Full Text] [Related]
34. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing. Izumi K, Kurosaka D, Iwata T, Oguchi Y, Tanaka Y, Mashima Y, Tsubota K. Invest Ophthalmol Vis Sci; 2006 Feb 15; 47(2):591-8. PubMed ID: 16431955 [Abstract] [Full Text] [Related]
37. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells. Steller MA, Delgado CH, Bartels CJ, Woodworth CD, Zou Z. Cancer Res; 1996 Apr 15; 56(8):1761-5. PubMed ID: 8620490 [Abstract] [Full Text] [Related]
39. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells. Vitale G, van Koetsveld PM, de Herder WW, van der Wansem K, Janssen JA, Colao A, Lombardi G, Lamberts SW, Hofland LJ. Am J Physiol Endocrinol Metab; 2009 Mar 15; 296(3):E559-66. PubMed ID: 19141687 [Abstract] [Full Text] [Related]